UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Testosterone levels and testosterone kinetics: The importance of its clinical significance

Radiotherapy and oncology, 2022-04, Vol.169, p.148-149

Zapatero, Almudena

2022

Link zum Volltext

Verfügbarkeit prüfen

Node Oligorecurrence in Prostate Cancer: A Challenge

Cancers, 2023-08, Vol.15 (16), p.4159

2023

Link zum Volltext

Verfügbarkeit prüfen

Detection and dynamics of circulating tumor cells in patients with high-risk prostate cancer treated with radiotherapy and hormones: a prospective phase II study

Radiation oncology (London, England), 2020-06, Vol.15 (1), p.137-7, Article 137

2020

Link zum Volltext

Verfügbarkeit prüfen

Long-term Results of Two Prospective Bladder-sparing Trimodality Approaches for Invasive Bladder Cancer: Neoadjuvant Chemotherapy and Concurrent Radio-chemotherapy

Urology (Ridgewood, N.J.), 2012-11, Vol.80 (5), p.1056-1062

2012

Link zum Volltext

Verfügbarkeit prüfen

Health-related quality of life in men with localized prostate cancer treated with radiotherapy: validation of an abbreviated version of the Expanded Prostate Cancer Index Composite for Clinical Practice in Spain

Health and quality of life outcomes, 2021-09, Vol.19 (1), p.1-223, Article 223

2021

Link zum Volltext

Verfügbarkeit prüfen

Advances in Transversal Topics Applicable to the Care of Bladder Cancer Patients in the Real-World Setting

Cancers, 2022-08, Vol.14 (16), p.3968

2022

Link zum Volltext

Verfügbarkeit prüfen

ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer

Clinical and translational radiation oncology, 2023-07, Vol.41, p.100638-100638, Article 100638

2023

Link zum Volltext

Verfügbarkeit prüfen

ESTRO ACROP consensus recommendation on the target volume definition for radiation therapy of macroscopic prostate cancer recurrences after radical prostatectomy

Clinical and translational radiation oncology, 2023-11, Vol.43, p.100684-100684, Article 100684

2023

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Results After High-Dose Radiotherapy and Adjuvant Hormones in Prostate Cancer: How Curable Is High-Risk Disease?

International journal of radiation oncology, biology, physics, 2011-12, Vol.81 (5), p.1279-1285

2011

Link zum Volltext

Verfügbarkeit prüfen

Reporting of results in DART01/05 GICOR – Author's reply

The lancet oncology, 2015-06, Vol.16 (6), p.e258-e259

Zapatero, Almudena

2015

Link zum Volltext

Verfügbarkeit prüfen

Risk-Adapted Androgen Deprivation and Escalated Three-Dimensional Conformal Radiotherapy for Prostate Cancer: Does Radiation Dose Influence Outcome of Patients Treated With Adjuvant Androgen Deprivation? A GICOR Study

Journal of clinical oncology, 2005-09, Vol.23 (27), p.6561-6568

2005

Link zum Volltext

Verfügbarkeit prüfen

Predictive value of PAK6 and PSMB4 expression in patients with localized prostate cancer treated with dose-escalation radiation therapy and androgen deprivation therapy

Urologic oncology, 2014-11, Vol.32 (8), p.1327-1332

2014

Link zum Volltext

Verfügbarkeit prüfen

Impact of mean rectal dose on late rectal bleeding after conformal radiotherapy for prostate cancer: Dose–volume effect

International journal of radiation oncology, biology, physics, 2004-08, Vol.59 (5), p.1343-1351

2004

Link zum Volltext

Verfügbarkeit prüfen

Updated results of bladder-sparing trimodality approach for invasive bladder cancer

Urologic oncology, 2010-07, Vol.28 (4), p.368-374

2010

Link zum Volltext

Verfügbarkeit prüfen

Reply to Leonard P. Bokhorst and Berdine L. Heesterman’s Words of Wisdom re: High-dose Radiotherapy and Risk-adapted Androgen Deprivation in Localised Prostate Cancer (DART 01/05): 10-Year Results of a Phase 3 Randomised, Controlled Trial. Eur Urol. 2022;82:441

European urology, 2022-12, Vol.82 (6), p.e177-e178

2022

Link zum Volltext

Verfügbarkeit prüfen

Sensitivity of a helical diode array device to delivery errors in IMRT treatment and establishment of tolerance level for pretreatment QA

Journal of applied clinical medical physics, 2012-01, Vol.13 (1), p.111-123

2012

Link zum Volltext

Verfügbarkeit prüfen

Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer

Journal of clinical oncology, 2017-09, Vol.35 (27), p.3097-3104

2017

Link zum Volltext

Verfügbarkeit prüfen

Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium

The lancet oncology, 2023-03, Vol.24 (3), p.e121-e132

2023

Link zum Volltext

Verfügbarkeit prüfen

High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial

The lancet oncology, 2022-05, Vol.23 (5), p.671-681

2022

Link zum Volltext

Verfügbarkeit prüfen

Biochemical recurrence (BCR) surrogacy for clinical outcomes after radiotherapy for adenocarcinoma of the prostate (BCRSCRAP): A meta-analysis from MARCAP Consortium

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.391-391

2023

Link zum Volltext

Verfügbarkeit prüfen

SIMBOSPROST: Prevalence of metabolic syndrome and osteoporosis in prostate cancer patients treated with radiotherapy and androgen deprivation therapy: A multicentre, cross-sectional study

Reports of practical oncology and radiotherapy, 2015-09, Vol.20 (5), p.370-376

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 68

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(62)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(46)
Science & Technology
(46)
Humans
(38)
Oncology
(35)
Male
(34)
Prostate Cancer
(26)
Radiology, Nuclear Medicine & Medical Imaging
(17)
Radiotherapy
(17)
Aged
(16)
Middle Aged
(16)
Prostatic Neoplasms - Radiotherapy
(16)
Radiotherapy Dosage
(15)
Androgen Antagonists - Therapeutic Use
(13)
Prostatic Neoplasms - Pathology
(13)
Patients
(12)
Urology & Nephrology
(12)
Androgens
(11)
Prostatic Neoplasms - Drug Therapy
(11)
Prostatic Neoplasms - Therapy
(10)
Retrospective Studies
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial

Testosterone levels and testosterone kinetics: The importance of its clinical significance

Node Oligorecurrence in Prostate Cancer: A Challenge

Detection and dynamics of circulating tumor cells in patients with high-risk prostate cancer treated with radiotherapy and hormones: a prospective phase II study

Long-term Results of Two Prospective Bladder-sparing Trimodality Approaches for Invasive Bladder Cancer: Neoadjuvant Chemotherapy and Concurrent Radio-chemotherapy

Health-related quality of life in men with localized prostate cancer treated with radiotherapy: validation of an abbreviated version of the Expanded Prostate Cancer Index Composite for Clinical Practice in Spain

Advances in Transversal Topics Applicable to the Care of Bladder Cancer Patients in the Real-World Setting

ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer

ESTRO ACROP consensus recommendation on the target volume definition for radiation therapy of macroscopic prostate cancer recurrences after radical prostatectomy

Long-Term Results After High-Dose Radiotherapy and Adjuvant Hormones in Prostate Cancer: How Curable Is High-Risk Disease?

Reporting of results in DART01/05 GICOR – Author's reply

Risk-Adapted Androgen Deprivation and Escalated Three-Dimensional Conformal Radiotherapy for Prostate Cancer: Does Radiation Dose Influence Outcome of Patients Treated With Adjuvant Androgen Deprivation? A GICOR Study

Predictive value of PAK6 and PSMB4 expression in patients with localized prostate cancer treated with dose-escalation radiation therapy and androgen deprivation therapy

Impact of mean rectal dose on late rectal bleeding after conformal radiotherapy for prostate cancer: Dose–volume effect

Updated results of bladder-sparing trimodality approach for invasive bladder cancer

Reply to Leonard P. Bokhorst and Berdine L. Heesterman’s Words of Wisdom re: High-dose Radiotherapy and Risk-adapted Androgen Deprivation in Localised Prostate Cancer (DART 01/05): 10-Year Results of a Phase 3 Randomised, Controlled Trial. Eur Urol. 2022;82:441

Sensitivity of a helical diode array device to delivery errors in IMRT treatment and establishment of tolerance level for pretreatment QA

Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer

Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis

Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium

Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus

High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial

Prognostic impact of PSA nadir (n) ≥0.1 ng/mL within 6 months (m) after completion of radiotherapy (RT) for localized prostate cancer (PCa): An individual patient-data (IPD) analysis of randomized trials from the ICECAP collaborative

Biochemical recurrence (BCR) surrogacy for clinical outcomes after radiotherapy for adenocarcinoma of the prostate (BCRSCRAP): A meta-analysis from MARCAP Consortium

SIMBOSPROST: Prevalence of metabolic syndrome and osteoporosis in prostate cancer patients treated with radiotherapy and androgen deprivation therapy: A multicentre, cross-sectional study

Suchergebnisse filtern